When was Ambros Therapeutics's last funding round?

Ambros Therapeutics's most recent recorded round was Early Stage VC (Series A) in Dec 2025, raising $154.0M.

PrivateMarketView

How much has Ambros Therapeutics raised?

$154.0Macross 1 recorded rounds · Dec 2025 – Dec 2025

Most recently, Ambros Therapeutics raised $154.0M in its Early Stage VC (Series A) (Dec 2025).

Free account

More of Ambros Therapeutics with a free account

No card required

Membership and data by Private Market View

1 rounds

Dec 2025Early Stage VC (Series A)$154.0M▮

+ 1 more investors · free account

Ambros Therapeutics has raised $154 million across 1 recorded round since 2025. The largest was a $154 million Series A in Dec 2025.

9 investors are on record for Ambros Therapeutics, including RA Capital Management, Arkin Capital, Adage Capital Management and Balyasny Asset Management. The Series A in Dec 2025 drew 8 investors.

For fundraisers

Raising for a company like Ambros Therapeutics?

9 investors have backed Ambros Therapeutics — start your target list with the firms already writing checks in biotechnology.

How much has Ambros Therapeutics raised?: Ambros Therapeutics has raised $154.0M in total across 1 recorded funding rounds.
When was Ambros Therapeutics's last funding round?: Ambros Therapeutics's most recent recorded round was Early Stage VC (Series A) in Dec 2025, raising $154.0M.